Antimalondialdehyde Low-Density Lipoprotein Antibody Levels Predict Low-Attenuation Plaque in the SCOT-HEART Trial
JACC Cardiovasc Imaging
.
2024 Jan;17(1):98-100.
doi: 10.1016/j.jcmg.2023.07.006.
Epub 2023 Aug 30.
Authors
Adam Hartley
,
Michelle C Williams
,
Amit Kaura
,
Mikhail Caga-Anan
,
Damini Dey
,
Marc R Dweck
,
Dorian O Haskard
,
David E Newby
,
Ramzi Y Khamis
PMID:
37656117
DOI:
10.1016/j.jcmg.2023.07.006
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic
Heart
Humans
Lipoproteins, LDL
Plaque, Atherosclerotic*
Predictive Value of Tests
Substances
Lipoproteins, LDL
Grants and funding
CH/09/002/26360/BHF_/British Heart Foundation/United Kingdom
FS/17/16/32560/BHF_/British Heart Foundation/United Kingdom
FS/ICRF/20/26002/BHF_/British Heart Foundation/United Kingdom
WT_/Wellcome Trust/United Kingdom